Loading...
XASE
YCBD
Market cap2mUSD
Jul 09, Last price  
0.81USD
1D
8.00%
1Q
19.10%
IPO
-99.96%
Name

Level Brands Inc

Chart & Performance

D1W1MN
XASE:YCBD chart
P/E
P/S
0.13
EPS
Div Yield, %
Shrs. gr., 5y
32.00%
Rev. gr., 5y
-14.45%
Revenues
19m
-1.50%
2,031,5624,474,953459,09123,651,55041,883,73444,480,76335,403,22424,155,36219,482,16719,190,468
Net income
-2m
L-44.84%
-3,356,489-1,738,734-412,075-50,428,22612,602,272-23,394,889-70,083,693-22,938,209-3,700,126-2,040,902
CFO
-1m
L+311.68%
-2,897,254-2,329,841-5,573,095-15,377,467-10,664,336-14,093,433-14,967,150-4,302,051-352,792-1,452,375

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
IPO date
Nov 17, 2017
Employees
90
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT